Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression

Citation
R. Stanzione et al., Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression, LAB INV, 81(1), 2001, pp. 51-59
Citations number
59
Categorie Soggetti
Medical Research General Topics
Journal title
LABORATORY INVESTIGATION
ISSN journal
00236837 → ACNP
Volume
81
Issue
1
Year of publication
2001
Pages
51 - 59
Database
ISI
SICI code
0023-6837(200101)81:1<51:VOPKPE>2.0.ZU;2-3
Abstract
Proline-rich kinase 2 (Pyk2), also known as CAK beta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to foc al adhesion kinase. Pyk2 is expressed in different cell types including bra in cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapi dly tyrosine phosphorylated in response to diverse extracellular signals ac ting via different post receptor pathways. We have investigated whether thi s protein kinase is functionally expressed in normal and neoplastic prostat e tissues. In this study, we demonstrate that Pyk2 is expressed only in nor mal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignan cy of prostate cancer.